Comparison of the Effects of Mirror Therapy,rTMS and Robotic-assisted Hand Therapy in Stroke Patients
Launched by AFYONKARAHISAR HEALTH SCIENCES UNIVERSITY · Dec 20, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying different therapies to help stroke patients improve their arm and hand function, manage pain, and enhance their overall quality of life. The researchers want to compare three types of treatments: mirror therapy, which uses a mirror to create the illusion of movement in the affected limb; repetitive transcranial magnetic stimulation (rTMS), a non-invasive technique that stimulates the brain; and robotic-assisted hand therapy, which uses robotic devices to assist with movement. These treatments will be added to regular rehabilitation programs to see which is most effective.
To participate in this trial, individuals must be between the ages of 40 and 80, have experienced a stroke at least three months ago, and be in good health for rehabilitation. They must also be mentally stable and able to understand the study. Participants will receive one of the therapies along with regular rehabilitation and will be monitored for their progress. It’s important to note that certain health conditions may prevent someone from joining, such as serious heart issues, cognitive problems, or recent surgeries on the affected side. This trial is currently looking for volunteers, so interested individuals should check with their healthcare provider to see if they qualify.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who applied to Afyonkarahisar Health Sciences University Hospital Physical Medicine and Rehabilitation Polyclinic with the diagnosis of hemiplegia after a cerebrovascular accident in the inpatient ward or as an outpatient for neurological rehabilitation after taking the anamnesis and physical examination, who met the inclusion criteria and eliminated the exclusion criteria
- • Female and male patients between the ages of 40-80
- • stroke at least 3 months ago
- • voluntarily agreed to participate in the study regularly, whose health status is suitable for rehabilitation and who are medically stable
- • mini mental test score of 15 and above
- • Neurologically stable patient
- Exclusion Criteria:
- • significant comorbidities such as serious heart disease (aortic stenosis, angina, hypertrophic cardiomyopathy, arrhythmia, pacemaker) and uncontrolled hypertension
- • history of epilepsy, antiepileptic drug use
- • intracranial metal objects
- • intraauricular implants
- • cognitive dysfunction
- • upper extremity peripheral nerve injuries
- • malignancy
- • active infection
- • skin infections or open wounds in the application area
- • inflammatory diseases
- • orthopedic injuries that may limit maximum effort capacity
- • brain lesion or drug use history that may affect the seizure threshold
- • increased intracranial pressure
- • uncontrolled migraine
- • severe spasticity in the hand (MAS≥3)
- • contracture in the hand
- • have had a fracture or surgery on the hemiplegic side in the last 6 months
- • severe visual impairment
- • severe depression
About Afyonkarahisar Health Sciences University
Afyonkarahisar Health Sciences University is a prominent academic institution dedicated to advancing healthcare through innovative research and clinical trials. Located in Turkey, the university focuses on integrating cutting-edge scientific inquiry with practical applications in medicine and health sciences. Committed to fostering collaboration among researchers, healthcare professionals, and institutions, Afyonkarahisar Health Sciences University aims to enhance patient care and contribute to the global body of medical knowledge through rigorous clinical trials and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Afyonkarahisar, , Turkey
Patients applied
Trial Officials
Selma Eroglu, MD
Principal Investigator
Afyonkarahisar Health Sciences University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported